Poland is one of the most difficult markets in Europe to achieve market access for pharmaceutical products. High prices on branded drugs, the wide availability of generics and an arduous reimbursement process create a challenging environment for manufacturers. With very strict laws for marketing of branded products, it is imperative to connect with the right opinion leaders to achieve reimbursement.
Any correspondence or materials produced by a pharmaceutical company about medicines or their use is considered promotional, whether or not they make product-specific claims. The Polish Pharmaceutical Law Act, which is dedicated to the advertising of medical products, defines advertising broadly and is interpreted to cover all promotional activities and direct marketing.
Sign up to get the guides
Select the guides you wish to download